Hexagon Nutrition Limited logo

Hexagon Nutrition Limited

HEXAGONListed

Mainboard IPO · NSE, BSE

Price Band

₹42 – ₹45

Lot Size

333 shares

Issue Size

₹139 Cr

GMP (Grey Market Premium)

🔒 Login to view

About Hexagon Nutrition Limited

Hexagon Nutrition Limited is a research-oriented nutrition company engaged in the development, manufacturing, and marketing of a wide range of nutrition products. The company operates across the nutrition value chain, offering micronutrient premixes, therapeutic and clinical nutrition products, and solutions for food fortification and malnutrition. It provides customised vitamin and mineral premixes to domestic and international fast-moving consumer goods companies and also supplies micronutrient powders for public health programmes. Its product portfolio addresses various nutritional needs, including clinical nutrition and preventive healthcare. The company follows an integrated business model, with capabilities spanning research and development, production, and distribution, and focuses on quality-driven offerings. Revenue is primarily generated through the sale of these nutrition products across different customer segments, including institutional and commercial clients. Discuss on Trading Q&A

Issue Details
IPO Open Date5 Jun 2026
IPO Close Date9 Jun 2026
Basis of Allotment10 Jun 2026
Refunds Initiation11 Jun 2026
Listing Date12 Jun 2026
Face Value
Fresh Issue
Offer for Sale
Minimum Investment (Retail)₹14,985
Registrar
Lead Managers
IPO Timeline
Issue open date5 Jun 2026
Issue close date9 Jun 2026
UPI mandate deadline9 Jun 2026
Allotment finalization10 Jun 2026
Refund initiation11 Jun 2026
Share credit11 Jun 2026
Listing date12 Jun 2026
Mandate end date24 Jun 2026
Lock-in end date for anchor investors (50%)9 Jul 2026
Lock-in end date for anchor investors (remaining)7 Sept 2026
Strengths
  • Integrated nutrition company with capabilities from R&D to manufacturing and marketing.
  • Diverse product portfolio covering premixes, clinical, and therapeutic nutrition.
  • Strong presence in micronutrient premixes for FMCG companies.
  • Supplier to global public health programmes for micronutrient powders.
  • Focus on research-driven and quality-oriented product development.
Risks
  • Heavy dependence on the premix formulation segment for revenue.
  • High revenue concentration from a limited number of customers.
  • Exposure to raw material price volatility due to a lack of long-term contracts.
  • Risk of product quality issues leading to liability and reputational damage.
  • Dependence on successful R&D and new product commercialisation.
Subscription Status

Live subscription

Sign in to track subscription in real time.

Grey Market Premium

Grey market premium

Sign in to view live GMP and the estimated listing.